Back to Search
OLGA GOODMAN, M.D.
M.D.
Rheumatology Physician
NPI: 1407081698IndividualAccepts Medicare
Education
OTHER
Class of 1996
Research & Publications (14)
Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2.
PMID 17912448·Int J Oncol·2007
7-preclinical
Neprilysin inhibits angiogenesis via proteolysis of fibroblast growth factor-2.
PMID 16940054·J Biol Chem·2006
8-other
Is there a role for LHRH antagonists in prostate cancer?
PMID 19626832·Oncology (Williston Park)·2009
8-other
Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors.
PMID 19505924·Cancer Epidemiol Biomarkers Prev·2009
8-other
Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis.
PMID 17563767·Prostate Cancer Prostatic Dis·2008
7-preclinical
Bombesin attenuates pre-mRNA splicing of glucocorticoid receptor by regulating the expression of serine-arginine protein p30c (SRp30c) in prostate cancer cells.
PMID 17540466·Biochim Biophys Acta·2007
8-other
Lentiviral vector neutral endopeptidase gene transfer suppresses prostate cancer tumor growth.
PMID 17415380·Cancer Gene Ther·2007
7-preclinical
Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoter.
PMID 16949732·Mol Cell Endocrinol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 150 N RIVER RD STE 270
DES PLAINES, IL 60016 - Phone
- (847) 298-8470
Quick Facts
- NPI
- 1407081698
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 30
- Publications
- 14
Are you this provider?
Claim Your Profile